First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma

BACKGROUND: Recent advances in targeted therapy and immunotherapy have improved the prognosis of melanoma patients but brain metastasis remains a major challenge. Currently, it is unclear how existing therapies can be best used to prevent or treat brain metastasis in melanoma patients. AIMS: We aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xuechen, Haaland, Benjamin, Hu‐Lieskovan, Siwen, Colman, Howard, Holmen, Sheri L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714542/
https://www.ncbi.nlm.nih.gov/pubmed/34137219
http://dx.doi.org/10.1002/cnr2.1419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714542/
https://www.ncbi.nlm.nih.gov/pubmed/34137219
http://dx.doi.org/10.1002/cnr2.1419

Ejemplares similares